Related Experiment Videos
Which children should receive growth hormone treatment. Cost-benefit analysis is the key
1Department of Child Life and Health, University of Edinburgh, Scotland, UK. chriskelnar@hotmail.com
Archives of Disease in Childhood
|August 19, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Growth hormone for short children--whom should we be treating and why?
The journal of the Royal College of Physicians of Edinburgh·2012
Growth and skeletal development in families with NOGGIN gene mutations.
Hormone research·2008
Comparison of androgen receptor and oestrogen receptor beta immunoexpression in the testes of the common marmoset (Callithrix jacchus) from birth to adulthood: low androgen receptor immunoexpression in Sertoli cells during the neonatal increase in testosterone concentrations.
Reproduction (Cambridge, England)·2001
Idiopathic short stature.
Journal of pediatric endocrinology & metabolism : JPEM·2001
Prevalence of physical symptoms persisting in children a year after the Türkiye earthquake.
Archives of disease in childhood·2026
Evolving landscape of paediatric sepsis: progress, gaps and the next generation of tools.
Archives of disease in childhood·2026
Paediatric familial hypercholesterolaemia in Australia: a real-world registry study.
Archives of disease in childhood·2026
Quality and concordance of international paediatric sepsis guidelines: a cross-sectional appraisal from the SENTINEL International study.
Archives of disease in childhood·2026
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.
Journal of comparative effectiveness research·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026